News
Public · Published
Bausch + Lomb (BLCO) reports Q3: everything you need to know ahead of earnings
Bausch + Lomb will report third-quarter results on Wednesday before the market opens. Last quarter, revenue was $1.39 billion, up 9.1% year on year. The market expects revenue to grow 7.1% this quarter, the same pace as the same quarter last year.
Published:
Updated:
What happened
Bausch + Lomb will report third-quarter results on Wednesday before the market opens. Last quarter, revenue was $1.39 billion, up 9.1% year on year. The market expects revenue to grow 7.1% this quarter, the same pace as the same quarter last year.
Confirmed
Global impact / market context
The 7.1% expected growth matters because slower growth than last quarter's 9.1% could mean the business is cooling. If revenue merely matches expectations, investors may focus on costs and profit per sale, which means how much profit each dollar of sales produces, to judge whether results are good enough.
Analyst inference
Analysts reconfirmed their estimates over the last 30 days, suggesting they expect steady results. Peer results were mixed: Intuitive Surgical grew revenue 21.7% and beat estimates, while Neogen grew 6.5% and topped estimates. Intuitive Surgical shares traded down 2.3% after its results, showing strong revenue alone may not lift a stock.
Analyst inference
What to watch
- Watch Bausch + Lomb's reported revenue against the 7.1% year-on-year growth the market expects this quarter, and compare it with last quarter's 9.1% growth and $1.39 billion in revenue. Confirmed
- Watch whether management repeats or changes its full-year revenue guidance, which means its own forecast for the year, since last quarter's guidance met analysts' expectations and any cut could hurt shares. Proposed
- Watch reported costs and profit per sale, which means how much profit each dollar of revenue produces, because matching revenue expectations may not be enough if peers like Intuitive Surgical fell after beating revenue estimates. Analyst inference